Showing results (61-70 of 89) with videos related to
Sort By:
Pageof 9
European Journal of Clinical Pharmacology|January 1, 1982
Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phaseM I Nilsson, E Anggård, J Holmstrand, et al.Psychiatry Research|October 1, 1986
CSF levels of receptor-active endorphins in schizophrenic patients: correlations with symptomatology and monoamine metabolitesL H Lindström, G Besev, L M Gunne, et al.Neuroreport|July 28, 1997
(-)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's diseaseA Ekesbo, P E Andrén, L M Gunne, et al.Journal of Neural Transmission|January 1, 1983
Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesiasJ E Häggström, L M Gunne, A Carlsson, et al.European Journal of Clinical Pharmacology|August 1, 1979
Pharmacokinetics of methadone during maintenance therapy: pulse labeling with deuterated methadone in the steady stateE Anggård, M I Nilsson, J Holmstrand, et al.Journal of Consulting and Clinical Psychology|October 30, 2001
One-Session treatment of specific phobias in youths: a randomized clinical trialL G Ost, L Svensson, K Hellström, et al.Behaviour Research and Therapy|January 12, 2001
One vs five sessions of exposure and five sessions of cognitive therapy in the treatment of claustrophobiaL G Ost, T Alm, M Brandberg, et al.Pharmacology, Biochemistry, and Behavior|October 1, 1993
Modulation of oral movements by intranigral 5-hydroxytryptamine receptor agonists in the ratU Liminga, A E Johnson, P E Andrén, et al.Psychopharmacology|February 1, 1996
High frequency oral movements induced by long-term administration of amperozide but not FG5803 in ratsU Liminga, P E Andren, L S Ohlund, et al.Behaviour Research and Therapy|June 27, 1998
Recognition bias for safe faces in panic disorder with agoraphobiaL G Lundh, U Thulin, S Czyzykow, et al.Pageof 9